INVICTUS MD STRATEGIES CORP Inactive Instrument
Invictus MD Strategies Corp Share Price Toronto S.E.
Equities
GENE
CA46183X2086
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - CAD | - |
|
| Sales 2018 | 2.36 3.23 197.48 | Sales 2019 | 4.69 6.42 391.94 | Capitalization | 10Cr 14Cr 864.53Cr |
|---|---|---|---|---|---|
| Net income 2018 | -1.9Cr -2.6Cr -158.69Cr | Net income 2019 | -3.5Cr -4.79Cr -292.32Cr | EV / Sales 2018 | 4,58,33,024 x |
| Net cash position 2018 | 3.76Cr 5.14Cr 313.98Cr | Net Debt 2019 | 38.45L 52.58L 32Cr | EV / Sales 2019 | 2,28,77,117 x |
| P/E ratio 2018 |
-5.87
x | P/E ratio 2019 |
-2.45
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 6.83% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 09/19/09 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 24/17/24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 09/19/09 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22/22/22 |
Greg Macdonald
BRD | Director/Board Member | - | 26/21/26 |
Invictus MD Strategies Corp. is a Canada-based investment holding company. The Company is primarily engaged in the investment, acquisition, and development of synergistic businesses. The Company holds cash, investments in marketable securities, investments in private companies, and loans receivable. The Companyâs wholly owned subsidiaries include Greener Pastures MD Ltd., Prestige Worldwide Holdings Inc., 2102168 Alberta Ltd. and 2015059 Alberta Ltd.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +9.94% | 498.97Cr | |
| -32.21% | 360.87Cr | |
| -1.43% | 309.74Cr | |
| -25.09% | 264.21Cr | |
| -11.46% | 231.64Cr | |
| +36.65% | 184.7Cr | |
| +37.15% | 143.09Cr | |
| -16.01% | 138.93Cr | |
| +40.95% | 137.23Cr |
- Stock Market
- Equities
- IVITF Stock
- GENE Stock
